-Caveat Lector-

This article from NYTimes.com
has been sent to you by [EMAIL PROTECTED]


/-------------------- advertisement -----------------------\

Explore more of Starbucks at Starbucks.com.
http://www.starbucks.com/default.asp?ci=1015
\----------------------------------------------------------/

Bush Chooses U.S. Executive for AIDS Job

July 3, 2003
 By ELISABETH BUMILLER






WASHINGTON, July 2 - On the eve of a presidential visit to
Africa, President Bush today nominated Randall Tobias, a
former chairman and chief executive of Eli Lilly & Company,
to run a $15 billion program to fight AIDS worldwide.

Mr. Tobias, a major donor to Mr. Bush and the Republican
Party, and a resident of Indianapolis, has little
experience with AIDS issues or with Africa, where most of
the program's money will be directed. But the president
hailed Mr. Tobias in the Roosevelt Room of the White House
this morning as "one of America's most talented and
respected executives," and a man who "has shown the ability
to manage complex organizations and to navigate government
bureaucracies."

If confirmed by the Senate, Mr. Tobias, 61, will have the
rank of ambassador and will report directly to Secretary of
State Colin L. Powell, who has said he regards AIDS as the
pre-eminent crisis facing the world today. Mr. Tobias will
direct a new State Department office and will have broad
influence, Mr. Bush said, over all the government's
anti-AIDS programs and resources.

"Randy Tobias has a mandate directly from me to get our
AIDS initiative up and running as soon as possible," Mr.
Bush said.

Mr. Tobias, in prepared remarks in the Roosevelt Room, said
that "the statistics that describe the H.I.V./AIDS pandemic
are really nearly incomprehensible" but that he would
approach his new job "with enthusiasm and with optimism."

AIDS groups said they were surprised by the nomination of
Mr. Tobias, which was first reported on Tuesday in The
Washington Post. Some AIDS experts said they were
apprehensive about Mr. Tobias' lack of experience in Africa
and with AIDS, and his close ties to the pharmaceutical
industry, which has fought the use of generic drugs.

The issue is of great importance, because brand-name
anti-AIDS drugs can cost $10,000 to $12,000 a year per
patient in the United States. But generic anti-AIDS drugs
can cost as little as $300 per patient per year in poor
nations.

Mr. Bush promised today to move quickly to get low-cost
anti-retroviral medications into the hands of poor
patients, but some AIDS groups said they were still
skeptical about Mr. Tobias.

"We're concerned about whether or not he can be an honest
broker," said Paul Zeitz, the executive director of the
Global AIDS Alliance. "He'll be protecting the interests of
the pharmaceutical industry versus cost-effective
generically manufactured drugs."

Other AIDS groups said they would reserve judgment on Mr.
Tobias. "There does seem to be some management acumen and
the ability to pull a lot of levers," said Mark Isaac, vice
president of the Elizabeth Glaser Pediatric AIDS
Foundation.

Mr. Bush signed the administration's initiative to fight
AIDS worldwide into law on May 27. The program is to
provide $15 billion over five years, a tripling of the
existing amount. It will go to prevention and treatment
programs in 12 African nations as well as Haiti and Guyana.


Mr. Tobias, who was also chairman and chief executive of
AT&T International, was named C.E.O. of the Year by Working
Mother magazine in 1996 for what the publication said were
his family-friendly policies at Eli Lilly. He stepped down
from Lilly in 1999, and more recently has thrown his
political support behind Mitchell E. Daniels Jr., a former
Lilly executive and the recently departed White House
budget director who is now running for governor of Indiana.






http://www.nytimes.com/2003/07/03/international/africa/03AIDS.html?ex=1058221838&ei=1&en=fff4d2c31a23a6b2


---------------------------------

Get Home Delivery of The New York Times Newspaper. Imagine
reading The New York Times any time & anywhere you like!
Leisurely catch up on events & expand your horizons. Enjoy
now for 50% off Home Delivery! Click here:

http://www.nytimes.com/ads/nytcirc/index.html



HOW TO ADVERTISE
---------------------------------
For information on advertising in e-mail newsletters
or other creative advertising opportunities with The
New York Times on the Web, please contact
[EMAIL PROTECTED] or visit our online media
kit at http://www.nytimes.com/adinfo

For general information about NYTimes.com, write to
[EMAIL PROTECTED]

Copyright 2003 The New York Times Company

www.ctrl.org
DECLARATION & DISCLAIMER
==========
CTRL is a discussion & informational exchange list. Proselytizing propagandic
screeds are unwelcomed. Substance—not soap-boxing—please!   These are
sordid matters and 'conspiracy theory'—with its many half-truths, mis-
directions and outright frauds—is used politically by different groups with
major and minor effects spread throughout the spectrum of time and thought.
That being said, CTRLgives no endorsement to the validity of posts, and
always suggests to readers; be wary of what you read. CTRL gives no
credence to Holocaust denial and nazi's need not apply.

Let us please be civil and as always, Caveat Lector.
========================================================================
Archives Available at:

http://www.mail-archive.com/[EMAIL PROTECTED]/
<A HREF="http://www.mail-archive.com/[EMAIL PROTECTED]/">ctrl</A>
========================================================================
To subscribe to Conspiracy Theory Research List[CTRL] send email:
SUBSCRIBE CTRL [to:] [EMAIL PROTECTED]

To UNsubscribe to Conspiracy Theory Research List[CTRL] send email:
SIGNOFF CTRL [to:] [EMAIL PROTECTED]

Om

Reply via email to